Pharmacokinetics and Pharmacodynamics Study of LBS-008 in Healthy Volunteers Aged 50-85
Status:
Not yet recruiting
Trial end date:
2023-02-01
Target enrollment:
Participant gender:
Summary
This is a Phase 1b, parallel single-dose study to evaluate the pharmacokinetics (PK) and
pharmacodynamics (PD) of Tinlarebant when administered as an oral dose to elderly healthy
volunteers. This study will evaluate 2 dose levels in 2 cohorts comprising up to a total of
16 participants (8 per cohort). Dose levels will be evaluated in parallel.